coronavirus: eli lilly ceo david ricks on development of therapies
Published 4 years ago • 4.2K plays • Length 6:49Download video MP4
Download video MP3
Similar videos
-
6:05
eli lilly ceo david ricks on q2 results: seeing unbelievable demand for zepbound and mounjaro
-
19:58
facing forward: eli lilly ceo david ricks on covid-19 treatments
-
3:32
eli lilly ceo david ricks on the end of antibody study in hospitalized patients
-
3:46
eli lilly ceo david ricks on positive alzheimer's drug trial data
-
32:01
eli lilly ceo david ricks on coronavirus treatment developments (full stream 12/15)
-
3:41
2019 catalyst awards: david a. ricks, chairman & ceo, eli lilly and company
-
5:56
eli lilly ceo says science will win in covid fight
-
4:57
health care bucks sell-off as eli lilly soars: mizuho's jared holz on what's next for the group
-
9:22
eli lilly ceo discusses its coronavirus antibody drug and the latest on its breast cancer treatment
-
1:41
eli lilly ceo explains supply chain of covid-19 antibody drug
-
2:47
eli lilly hopes to start testing coronavirus cure 'this summer': ceo
-
4:26
eli lilly ceo david ricks breaks down second-quarter earnings and drug pipeline
-
3:14
eli lilly ceo on raising $1b for antibiotic research: goal is to have two to four new antibiotics
-
4:39
eli lilly ceo on how covid-19 antibody drug helped drive q4 earnings
-
4:29
eli lilly ceo david ricks breaks down q1 earnings, obesity drug trial results
-
4:12
eli lilly ceo david ricks explains q1 earnings miss, lowered forecast
-
8:21
eli lilly ceo talks partnering with abcellera biologics to co-develop a coronavirus cure
-
7:33
watch cnbc's full interview with eli lilly ceo david ricks
-
4:03
lyft ceo david risher on q2 results
-
2:13
eli lilly ceo on covid antibody treatment's effectiveness against mutations
-
4:40
eli lilly ceo on who advising against using remdesivir to treat covid-19
-
1:44
eli lilly confirms it has paused one of its covid-19 antibody tests